|
Federal
Register Notices > Notices
of Registration - 2004 > Mallinckrodt Inc.
FR Doc 04-18928
[Federal Register: August 18, 2004 (Volume 69, Number 159)]
[Notices]
[Page 51331]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18au04-92]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Registration
By Notice dated March 5, 2004, and published in
the Federal Register on March 15, 2004, (69 FR 12179), Mallinckrodt
Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances:
| Drug |
Schedule |
| Tetrahydrocannabinols (7370) |
I |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Difenoxin (9168) |
I |
| Morphine-N-oxide (9307) |
I |
| Normorphine (9313) |
I |
| Norlevorphanol (9634) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Codeine (9050) |
II |
| Diprenorphine (9058) |
II |
| Etorphine HCL (9059) |
II |
| Dihydrocodeine (9120) |
II |
| Hydromorphone (9150) |
II |
| Oxycodone (9143) |
II |
| Diphenoxylate (9170) |
II |
| Benzoylecgonine (9180) |
II |
| Hydrocodone (9193) |
II |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Methadone Intermediate (9254) |
II |
| Metopon (9260) |
II |
| Dextropropoxyphene (9273) |
II |
| Thebaine (9333) |
II |
| Opium extracts (9610) |
II |
| Opium fluid extract (9620) |
II |
| Opium tincture (9630) |
II |
| Opium, powdered (9639) |
II |
| Opium, granulated (9640) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Alfentanil (9737) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
The company plans to manufacture the listed
controlled substances for internal use and for sale to other companies.
No comments or objections have been received. DEA
has considered the factors in 21
U.S.C. 823(a) and determined that the registration of Mallinckrodt
Inc. to manufacture the listed basic classes of controlled substances is
consistent with the public interest at this time. DEA has investigated
Mallinckrodt Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant to
21 U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: July 28, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-18928 Filed 8-17-04; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
